Three Venerable Acronyms Fade Away As Cooperative Groups Form “Alliance”
ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number
Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board
GAO Decision Clears NCI to Deploy Medidata Rave Data Capture System
FDA Updates Safety Information for 5-Alpha Reductase Inhibitors
ACS Report Says Drop in Cancer Mortality Saved 898,000 Lives Over 17 Years
Stand Up To Cancer Co-Founder Laura Ziskin Dies of Complications From Breast Cancer at 61
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program









